Ilex&#39;s Leukemia Drug Shows Some Benefits-FDA Panel
555792
A panel of medical experts on Wednesday said Ilex Oncology Inc.&#39;s new drug Clolar was &quot;reasonably likely&quot; to help children and young adults with a cancer called acute lymphocytic leukemia.
586343
U.S. regulators said on Thursday they were reviewing two recent studies that provided more evidence of serious risks for some cancer patients treated with anemia drugs sold by Amgen Inc  and Johnson & Johnson .
537171
The kidney cancer pill Nexavar has shown promise in treating a small number of people with a type of blood cancer known as acute myeloid leukemia or AML, U.S. researchers said on Tuesday.
416254
CAMBRIDGE, Massachusetts The drug Clolar has won Food and Drug Administration approval to treat patients ages one to 21 who have exhausted other treatment options for acute lymphoblastic leukemia.
500550
MONDAY, Dec. 11 (HealthDay News) -- A combination of three chemotherapy drugs -- pentostatin, cyclophosphamide and rituximab --  produced significant clinical response in patients with previously untreated chronic lymphocytic leukemia, according to a study presented Sunday at the American Society of Hematology annual meeting.
518874
WEDNESDAY, Sept. 29 (HealthDayNews) -- The anti-cancer drug Gleevec, highly touted for slowing the progression of chronic myeloid leukemia, also appears to stall a rare kind of skin cancer, a new study finds.
688289
The Food and Drug Administration approved Clolar, Genzyme Corp.'s new drug for patients under 21 with acute lymphocytic leukemia. An advisory panel on Dec. 1 recommended the drug be approved. Clolar was developed by Ilex Oncology Inc., the Texas firm Cambridge-based Genzyme acquired last week in a $1 billion stock transaction. The FDA panel recommended that more studies be done ...
494130
Genzyme Corp. announced Wednesday that its drug Clolar has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of children with difficult or relapsed acute lymphoblastic leukemia (ALL).
703630
U.S. Food and Drug Administration staff reviewers on Tuesday questioned clinical data for non-Hodgkin's lymphoma drug Marqibo, made by Inex Pharmaceuticals Corp. and Enzon Pharmaceuticals Inc..
229940
Swiss drugmaker Novartis AG's  cancer-fighting drug Gleevec can still help treat chronic  myeloid leukemia even after five years of use, a new study  showed on Wednesday.
485506
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells. The Food and Drug Administration approved the drug, Zolinza, to treat advanced cases of cutaneous T-cell lymphoma, a rare cancer that's a form of non-Hodgkin's lymphoma. Roughly 20,000 Americans have the cancer, Merck said.
664258
Arsenic may be a suitable first-line treatment for a rare form of leukaemia called acute promyeloctytic leukaemia (APL), an Iranian study claims.
24964
Blood from a newborn&#39;s umbilical cord, often thrown away but rich in cells that may rebuild the body&#39;s blood production system, is safe to treat leukemia in adults, two studies released on Wednesday show.
156528
WASHINGTON -- Women with an aggressive form of advanced breast cancer that other treatments have failed to stop gained a new option Tuesday with the approval of a novel drug _ but how much benefit it offers is unclear.
719234
US Food and Drug Administration staff reviewers on Tuesday questioned clinical data for non-Hodgkin&#39;s lymphoma drug Marqibo, made by Inex Pharmaceuticals Corp.
1957
A drug currently used to treat kidney cancer has shown promising results in treating the most common and deadly form of adult leukemia, according to a US study released Tuesday.
755755
JACKSONVILLE, FL -- The Food and Drug Administration is giving hope to children with Leukemia that don&#39;t respond to traditional treatments.